EU reveals proposals on pharma in TTIP talks
This article was originally published in Scrip
The European Commission has released a number of texts laying out the EU's proposals on specific issues, including pharmaceutical and medical device regulation, that are under discussion with the US government as part of the negotiations on the Transatlantic Trade and Investment Partnership (TTIP). The commission says this is the first time it has made such proposals public during bilateral trade talks, and that this "reflects its commitment to greater transparency in the negotiations".
You may also be interested in...
The UK BioIndustry Association has welcomed the government’s fresh investment in COVID-19 vaccine manufacturing capacity, while Sanofi and GSK are striking European and US deals for their vaccine candidate. A number of potential therapies are also being developed, including products based on interferon and hyperimmune globulin, but Roche/Chugai’s Actemra (tocilizumab) looks like a non-runner.
A parliamentary committee has come up with some ideas for strengthening the UK’s response to future demand surges due to the spread of COVID-19.
The European Medicines Agency is preparing to appoint its new executive director after nominee Emer Cooke presented her case to the European Parliament.